Tricuspid valve clipping for leaky valve
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests a new device that clips the tricuspid valve to stop blood from flowing backward. It is for people with severe tricuspid regurgitation (a leaky valve) who still have symptoms despite medical treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have severe or greater tricuspid regurgitation (leaky valve)
- Your symptoms (like shortness of breath, leg swelling) are not fully controlled with medications
- Your heart team believes surgery would be high risk and the clip could help
- You have not had a pacemaker or defibrillator (unless it won't interfere with the clip)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether a minimally invasive “clip” procedure can safely improve tricuspid valve leakage (a heart valve that doesn’t close tightly). It focuses on older adults who are considered too high-risk for open-heart surgery and still have enough heart pumping strength to benefit.
This study tests a device called TriClip to repair a leaky tricuspid valve in the heart. If the leak is reduced, you may have less shortness of breath and feel more energetic.
This trial studies a minimally invasive “edge-to-edge” clip procedure to reduce severe leakage of the tricuspid valve. It’s for people who still feel unwell despite standard treatments and may be too high-risk for open-heart surgery.
This study tests a new catheter-based device to repair a leaky tricuspid heart valve (tricuspid regurgitation) in people who still have symptoms like shortness of breath or swelling despite taking heart medications. The goal is to see if the procedure is safe and can help reduce the leak.
This study follows adults with a severely leaky tricuspid heart valve who still have symptoms despite medication. It looks at outcomes after a procedure called TriClip, which helps reduce valve leakage.
This trial studies whether a heart procedure called K-Clip TM helps people with severe “secondary” tricuspid valve leakage who are at high risk for open-heart surgery. It aims to improve symptoms and valve function using a less-invasive, catheter-based repair.
Hear when a new Severe or Greater Tricuspid Regurgitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.